Soros Fund Management’s MoonLake Immunotherapeutics MLTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-100,000	Closed	-$6.04M	–	206
2023 Q4	$6.04M	Buy	100,000 +44,000	+79%	+$2.66M	0.08%	108
2023 Q3	$3.19M	Buy	+56,000	New	+$3.19M	0.05%	126